Loading clinical trials...
Loading clinical trials...
A Phase II Single Arm Trial of Adding Simvastatin to Dual Anti-HER2 Therapy in Patients With HER2-Positive Metastatic Breast Cancer
Conditions
Interventions
Simvastatin 80mg
Locations
2
United States
Harris Health System - Smith Clinic
Houston, Texas, United States
O'Quinn Medical Tower - McNair Campus; Dan L Duncan Comprehensive Cancer Center
Houston, Texas, United States
Start Date
March 4, 2020
Primary Completion Date
December 1, 2028
Completion Date
December 1, 2030
Last Updated
February 27, 2025
NCT07459673
NCT06064812
NCT06830382
NCT07225309
NCT05837533
NCT06578299
Lead Sponsor
Baylor Breast Care Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions